Related Experiment Video

Updated: Jun 23, 2026

Colon Ascendens Stent Peritonitis (CASP) - a Standardized Model for Polymicrobial Abdominal Sepsis
06:45

Colon Ascendens Stent Peritonitis (CASP) - a Standardized Model for Polymicrobial Abdominal Sepsis

Published on: December 19, 2010

Cystatin C blood level as a risk factor for death after heart surgery

Didier Ledoux1, Mehran Monchi, Jean-Paul Chapelle

  • 1Intensive Care Unit, Liège University Hospital, Sart Tilman Bat B35, B-4000 Liège, Belgium. dledoux@chu.ulg.ac.be

European Heart Journal
|July 10, 2007
PubMed

Insights

Pre-operative cystatin C provides a more accurate assessment of kidney function than serum creatinine for predicting outcomes after heart surgery. This improved estimation helps identify patients at higher risk for mortality and morbidity.

Area of Science:

  • Cardiology
  • Nephrology
  • Medical Diagnostics

Background:

  • Pre-operative renal dysfunction is a significant risk factor for adverse outcomes in heart surgery patients.
  • Serum creatinine is commonly used to estimate glomerular filtration rate (GFR), but its accuracy is limited.
  • Cystatin C offers a more precise measure of GFR compared to serum creatinine.

Purpose of the Study:

  • To evaluate the association between pre-operative GFR estimated by cystatin C levels and hospital mortality, morbidity, and 1-year mortality after heart surgery.
  • To compare the predictive accuracy of cystatin C-based GFR with creatinine-based GFR for these outcomes.

Main Methods:

  • A prospective, single-center observational study included 376 patients undergoing heart surgery.
  • Serum creatinine and cystatin C levels were measured pre-operatively.
  • Hospital mortality, hospital morbidity (defined by prolonged length of stay), and 1-year mortality were recorded.

Main Results:

  • GFR estimated from cystatin C, unlike that from serum creatinine, was an independent predictor of hospital morbidity/mortality (OR 1.20 per 10 mL/min GFR decrease, P=0.001).
  • Cystatin C-based GFR also independently predicted 1-year mortality (HR 1.26 per 10 mL/min GFR decrease, P=0.002).
  • Hospital mortality was 5.6% and 1-year mortality was 10.2% in the study cohort.

Conclusions:

  • Pre-operative GFR estimation using serum cystatin C offers superior risk assessment compared to serum creatinine in patients undergoing heart surgery.
  • Cystatin C may improve the identification of high-risk patients, potentially guiding perioperative management.
Abstract

More Related Videos

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...